Esophageal cancer practice guidelines 2022 edited by the Japan esophageal society: part 1
2023 · Esophagus · 345 citations
https://doi.org/10.1007/s10388-023-00993-2
T
Tomoki Makino
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
445
Papers
7.0K
Citations
45
h-index
149
i10-index
Tomoki Makino is an academic researcher from The University of Osaka. The author has contributed to research in topics: Esophageal Cancer Research and Treatment & Gastric Cancer Management and Outcomes & Esophageal and GI Pathology. The author has an h-index of 45, co-authored 379 publications.
ORCID: 0000-0001-7918-4217Papers by this author
worksRole of multidrug resistance protein 2 (MRP2) in chemoresistance and clinical outcome in oesophageal squamous cell carcinoma
2011 · British Journal of Cancer · 132 citations
https://doi.org/10.1038/sj.bjc.6606071
Overexpression of glypican-1 implicates poor prognosis and their chemoresistance in oesophageal squamous cell carcinoma
2016 · British Journal of Cancer · 130 citations
https://doi.org/10.1038/bjc.2016.183
Density and maturity of peritumoral tertiary lymphoid structures in oesophageal squamous cell carcinoma predicts patient survival and response to immune checkpoint inhibitors
2023 · British Journal of Cancer · 100 citations
https://doi.org/10.1038/s41416-023-02235-9
Postoperative Infectious Complications are Associated with Adverse Oncologic Outcomes in Esophageal Cancer Patients Undergoing Preoperative Chemotherapy
2016 · Annals of Surgical Oncology · 73 citations
https://doi.org/10.1245/s10434-015-5045-7
TAS-116 inhibits oncogenic KIT signalling on the Golgi in both imatinib-naïve and imatinib-resistant gastrointestinal stromal tumours
2019 · British Journal of Cancer · 49 citations
https://doi.org/10.1038/s41416-019-0688-y
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat